News & Updates

Treatment with tenofovir alafenamide (TAF) for pregnant women with active chronic hepatitis B (CHB) infection, when administered throughout or initiated early in pregnancy, is effective and safe in both mothers and infants, according to a study.

Mild-to-moderate COVID-19 during pregnancy does not appear to affect the foetal brain, according to a prospective study presented at RSNA 2021.

In fatal cases of the coronavirus disease 2019 (COVID-19), cardiac inflammation, cardiomyocyte injury, and microvascular thrombogenicity are substantially lower in the second vs first wave of infections, a new study has found.

Among critically ill patients with COVID-19, those who present with lower baseline estimated glomerular filtration rate (eGFR) and reduced urine output at the time of kidney replacement therapy (KRT) initiation are more likely to experience kidney nonrecovery, according to a study.

In a cohort of veterans with COVID-19, former smokers are at higher risk of 30-day mortality compared with current smokers and nonsmokers, as reported in a study.

Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.

Diabetes does not appear to predispose SARS-CoV-2–infected patients to long-term post-COVID-19 symptoms, a study reports.